Work

Phase II study of eribulin mesylate (E7389) halichondrin b analog in patients with refractory breast cancer

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.1034

Authors: J. L. Blum, B. Pruitt, C. J. Fabian, R. R. Rivera, D. E. Shuster, N. L. Meneses, K. Chandrawansa, F. Fang, S. Z. Fields, L. Vahdat

Institutions: Cornell University, University of Kansas Medical Center, Harrington Cancer Center

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2275150197

Cites:

Cited by: 11

Related to: 10